CRISPR 基因組治療市場按產品類型、應用、最終用戶和地區分類

CRISPR Genomic Cure Market, By Product Type, By Application, By End User, By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年 CRISPR 基因組治療市場規模估計為 46.2 億美元，預計到 2032 年將達到 170.4 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 20.5%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	46.2億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年年複合成長率：	20.50%	2032年價值預測	170.4億美元

全球 CRISPR 基因組治療市場是全球生物技術產業中一個快速發展的領域。 CRISPR（成簇的規律間隔的短回文重複序列）是一種突破性的基因編輯技術，可對基因組 DNA 進行精確的定向改變。該技術有可能改變多種疾病的治療方法，包括遺傳疾病、癌症和感染疾病。 CRISPR 基因組治療市場的發展受到遺傳疾病日益普及的推動以及對有效治療方法日益成長的需求的驅動。該技術能夠以前所未有的精度修改基因，為治療以前被認為無法治癒的疾病開闢了新的可能性。此外，CRISPR 技術的進步，例如開發更有效率、更安全的基因編輯工具，預計將進一步推動該市場的成長。對研發活動的投資不斷增加以及生物技術公司和研究機構之間合作的不斷加強也促進了全球 CRISPR 基因組治療市場的擴張。然而，市場面臨著許多挑戰，包括與基因編輯相關的倫理和安全問題、監管障礙，以及開發和商業化基於 CRISPR 的治療方法的高成本。儘管面臨這些挑戰，但全球 CRISPR 基因組治療市場預計將在未來幾年實現顯著成長，這得歸功於該技術在醫療保健領域帶來的巨大變革潛力。總而言之，全球 CRISPR 基因組治療市場是一個充滿希望和活力的領域，有潛力為各種疾病的治療帶來重大進展。

市場動態：

慢性病、遺傳疾病、感染疾病、神經系統疾病、血液疾病和代謝性疾病盛行率上升、老年人口成長、對安全有效治療和療法的需求增加、細胞和基因治療資金增加、基因療法的頻繁核准、新療法的引入以及人們對全球 CRISPR 基因組治療市場的認知不斷提高，是預計在預測期內促進全球 CRISPR 基因組治療市場成長的關鍵因素。

例如，2021年3月，來自加州大學舊金山分校、加州大學柏克萊分校和加州大學洛杉磯分校（UCLA）的科學家獲得美國食品藥物管理局（FDA）的核准，共同啟動一項針對鐮狀細胞病患者的CRISPR基因校正療法的早期、首次人體臨床試驗，該療法將使用患者自身的造血幹細胞進行治療。與目前從健康骨髓捐贈者進行幹細胞移植的治療方法相比，該治療方法可以創造一種更安全、更便捷且可能治癒鐮狀細胞疾病的治療治療方法，從而徹底改變鐮狀狀細胞疾病的治療方式。此外，該治療方法還可以預防鐮狀細胞疾病不可逆的併發症。

本研究的主要特點

本報告對全球 CRISPR 基因組治療市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和年複合成長率。
它還揭示了各個領域的潛在商機，並解釋了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球 CRISPR 基因組治療市場的主要企業會根據以下參數進行分析，例如公司亮點、產品系列、關鍵亮點、財務表現和策略。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球 CRISPR 基因組治療市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過用於分析全球 CRISPR 基因組治療市場的各種策略矩陣來做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 4.62 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	20.50%	2032 Value Projection:	USD 17.04 Bn

The global CRISPR genomic cure market is a rapidly evolving sector within the global biotechnology industry. CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. This technology has the potential to transform the treatment of a wide range of diseases, including genetic disorders, cancers, and infectious diseases. The market for CRISPR genomic cures is driven by the increasing prevalence of genetic diseases and the growing demand for effective therapies. The technology's ability to modify genes with unprecedented precision has opened up new possibilities for the treatment of diseases that were previously considered untreatable. Moreover, advancements in CRISPR technology, such as the development of more efficient and safer gene-editing tools, are expected to further propel the growth of this market. The increasing investment in research and development activities, coupled with the growing collaboration between biotechnology companies and research institutes, is also contributing to the expansion of the global CRISPR genomic cure market. However, the market faces several challenges, including ethical and safety concerns related to gene editing, regulatory hurdles, and the high cost of developing and commercializing CRISPR-based therapies. Despite these challenges, the global CRISPR genomic cure market is expected to witness significant growth in the coming years, driven by the technology's immense potential to revolutionize healthcare. In conclusion, the global CRISPR genomic cure market represents a promising and dynamic field with the potential to bring about significant advancements in the treatment of various diseases.

Market Dynamics:

Increasing prevalence of chronic disease, genetic disease, infectious diseases, neurological disease, blood disease, and metabolic disease, a growing geriatric population, growing demand for safe and effective treatment or therapies, increasing funding for cell and gene therapies, frequent approvals for gene therapies, the introduction of novel therapies, and increasing awareness among people about the global CRISPR genomic cure market are major factors expected to augment the growth of the global CRISPR genomic cure market during the forecast period.

For instance, in March 2021, scientists at UC San Francisco, UC Berkeley, and UCLA received U.S. Food and Drug Administration (FDA) approval to jointly launch an early-phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient's own blood-forming stem cells. The therapy has the potential to transform sickle cell disease care by producing an accessible, curative treatment that is safer than the current therapy of stem cell transplant from a healthy bone marrow donor. Moreover, the therapy has the potential to prevent irreversible complications of the disease.

Key features of the study:

This report provides in-depth analysis of the global CRISPR genomic cure market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global CRISPR genomic cure market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., Origene Technologies, Inc., New England Biolabs, Intellia Therapeutics, Inc., GenScript, GeneCopoeia, Inc., Cellectis, Mammoth Biosciences, Precision Biosciences, Inc., Synthego Corporation, CRISPR Therapeutics, Horizon Discovery Group plc, Lonza Group Ltd., Takara Bio Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global CRISPR genomic cure market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global CRISPR genomic cure market

Detailed Segmentation:

By Product Type:
- Kits & Reagents
- Libraries
- Vector Design
- Assay Design
- Others
By Application:
- Oncology
- Genetic Diseases
- Genomic Engineering
- Others
By End User:
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Genetic Research Laboratories
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Origene Technologies, Inc.
- New England Biolabs
- Intellia Therapeutics, Inc.
- GenScript
- GeneCopoeia, Inc.
- Cellectis
- Mammoth Biosciences
- Precision Biosciences, Inc.
- Synthego Corporation
- CRISPR Therapeutics
- Horizon Discovery Group plc
- Lonza Group Ltd.
- Takara Bio Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- CRISPR Genomic Cure Market, By Product Type
- CRISPR Genomic Cure Market, By Application
- CRISPR Genomic Cure Market, By End User
- CRISPR Genomic Cure Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global CRISPR Genomic Cure Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global CRISPR Genomic Cure Market, By Product Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Kits & Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Libraries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Vector Design
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Assay Design
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global CRISPR Genomic Cure Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Genetic Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Genomic Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global CRISPR Genomic Cure Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Genetic Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global CRISPR Genomic Cure Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - UK
  - Germany
  - France
  - Spain
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - India
  - China
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of the APAC
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of LATAM
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Merck KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Origene Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
New England Biolabs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Intellia Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GenScript
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GeneCopoeia, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cellectis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mammoth Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Precision Biosciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Synthego Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
CRISPR Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Horizon Discovery Group plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lonza Group Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views